SCHEMBL8309619

SCHEMBL8309619

NC(Cc1cnccn1)(OC(=O)/C=C\C(=O)OC(N)(Cc1cnccn1)c1ccccc1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VNN1 O95497 2/20 0.38
CYP2C9 P11712 4/20 0.37
NAMPT P43490 1/20 0.37
IDO1 P14902 1/20 0.34
CYP1A2 P05177 3/20 0.33
CYP2C19 P33261 3/20 0.33
KDM4E B2RXH2 3/20 0.33
CYP3A4 P08684 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 1/20 0.33
HIF1A Q16665 1/20 0.33
KCNA5 P22460 1/20 0.33
P4HB P07237 1/20 0.33
TSHR P16473 1/20 0.32
HSP90AA1 P07900 1/20 0.32
HTT P42858 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8862529 0.79 CYP1A2 (0.42) VNN1CYP2C9NAMPTCYP1A2KDM4E
SCHEMBL8863067 0.77 VNN1 (0.37) VNN1CYP2C9NAMPTCYP1A2KDM4E
SCHEMBL3243595 0.76 VNN1 (0.43) VNN1CYP2C9NAMPTIDO1CYP1A2
SCHEMBL7823617 0.74 VNN1 (0.46) VNN1CYP2C9NAMPTIDO1CYP1A2
SCHEMBL7823614 0.74 VNN1 (0.46) VNN1CYP2C9NAMPTIDO1CYP1A2
SCHEMBL8866615 0.72 BLM (0.45) HIF1ASMN1; SMN2LMNA
SCHEMBL9226679 0.70 SMN1; SMN2 (0.43) CYP1A2CYP2C19KDM4EMEN1KMT2A
SCHEMBL9302445 0.69 VNN1 (0.42) VNN1CYP2C9NAMPTIDO1CYP1A2
SCHEMBL9302450 0.69 VNN1 (0.42) VNN1CYP2C9NAMPTIDO1CYP1A2
SCHEMBL9661857 0.68 KCNA5 (0.44) VNN1CYP2C9CYP1A2CYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0612314-B1 2-PYRAZINYLETHYLAMINE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS ASTRA AB (SE) 1999-12-29 EP disclosed
US-5607935-A 2-heterocyclicethylamine derivatives and their use as pharmaceuticals FISONS CORPORATION (US) 1997-03-04 US disclosed
EP-0540318-A1 2-Heterocyclicethylamine derivatives and their use as pharmaceuticals FISONS CORPORATION (US) 1993-05-05 EP disclosed